1. 2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis. (September 2015) Authors: Alekseev, B.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Cosgriff, T.; Collins, L.; Brechenmacher, T.; Lin, J.; Morgan, L.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis. (September 2015) Authors: Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Cosgriff, T.; Collins, L.; Brechenmacher, T.; Lin, J.; Morgan, L.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 432 Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapy. (September 2015) Authors: Glen, H.; Hsieh, J.; Michaelson, M.D.; Kim, H.J.; Sachdev, P.; Kadowaki, T.; Funahashi, Y.; Larkin, J.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 4LBA Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial. (September 2015) Authors: Choueiri, T.; Escudier, B.; Powles, T.; Mainwaring, P.; Rini, B.; Donskov, F.; Hammers, H.; Hutson, T.; Roth, B.; Peltola, K.; Lee, J.L.; Heng, D.; Schmidinger, M.; Borgman-Hagey, A.; Hessel, C.; Scheffold, C.; Schwab, G.; Tannir, N.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oral lichenoid reactions associated with anti‐PD‐1/PD‐L1 therapies: clinicopathological findings. (8th May 2017) Authors: Sibaud, V.; Eid, C.; Belum, V.R.; Combemale, P.; Barres, B.; Lamant, L.; Mourey, L.; Gomez‐Roca, C.; Estilo, C.L.; Motzer, R.; Vigarios, E.; Lacouture, M.E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 10(2017) Page Start: e464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗